TOWA PHARMACEUTICAL CO.,LTD. (4553)
Market cap
¥220.2B
P/E ratio
11.9x
Towa Pharmaceutical manufactures and sells generic drugs to hospitals and distributors in Japan, Europe, and North America through its own facilities and subsidiaries.
| Period End | FCF margin (%) | YoY (%) |
|---|---|---|
| Mar 31, 2025 | -2.1 | -84.20% |
| Mar 31, 2024 | -13 | +3.71% |
| Mar 31, 2023 | -12.5 | -288.96% |
| Mar 31, 2022 | 6.6 | +257.99% |
| Mar 31, 2021 | 1.9 | -86.00% |
| Mar 31, 2020 | 13.2 | +77.07% |
| Mar 31, 2019 | 7.5 | +46.95% |
| Mar 31, 2018 | 5.1 | -141.99% |
| Mar 31, 2017 | -12.1 | +1.30% |
| Mar 31, 2016 | -12 | +61.79% |
| Mar 31, 2015 | -7.4 |